Literature DB >> 9529433

Incidence of epilepsy is now higher in elderly people than children.

A D Everitt, J W Sander.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9529433      PMCID： PMC1112742          DOI： 10.1136/bmj.316.7133.780

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Epidemiology of the epilepsies.

Authors:  J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 2.  Epilepsy in childhood.

Authors:  B G Neville
Journal:  BMJ       Date:  1997-10-11

3.  National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population.

Authors:  J W Sander; Y M Hart; A L Johnson; S D Shorvon
Journal:  Lancet       Date:  1990-11-24       Impact factor: 79.321

4.  Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984.

Authors:  W A Hauser; J F Annegers; L T Kurland
Journal:  Epilepsia       Date:  1993 May-Jun       Impact factor: 5.864

5.  Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis.

Authors:  O C Cockerell; I Eckle; D M Goodridge; J W Sander; S D Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154
  5 in total
  3 in total

1.  Incidence of epilepsy in Ferrara, Italy.

Authors:  Edward Cesnik; Francesco Pedelini; Raffaella Faggioli; Vincenza Cinzia Monetti; Enrico Granieri; Ilaria Casetta
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

Review 2.  The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy.

Authors:  Mariana Alves; Edward Beamer; Tobias Engel
Journal:  Front Pharmacol       Date:  2018-03-07       Impact factor: 5.810

Review 3.  Classifying epilepsy pragmatically: Past, present, and future.

Authors:  Nathan A Shlobin; Gagandeep Singh; Charles R Newton; Josemir W Sander
Journal:  J Neurol Sci       Date:  2021-05-29       Impact factor: 4.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.